Statin use is associated with improved overall survival without affecting patency and limb salvage rates following

Hasan H Dosluoglu1, Sina Davari-Farid2, Leili Pourafkari2

  • 1Department of Anesthesiology, SUNY-Buffalo, Buffalo, NY, USA Department of Surgery, SUNY-Buffalo, Buffalo, NY, USA.

Insights

Statin drug use in chronic limb ischemia patients undergoing revascularization was linked to better survival rates. However, statins did not significantly impact vessel patency or limb salvage outcomes.

Area of Science:

  • Vascular Surgery
  • Cardiology
  • Pharmacology

Background:

  • Chronic limb ischemia (CLI) poses significant risks for patients requiring revascularization.
  • The role of statin therapy in optimizing outcomes after revascularization for CLI remains an area of investigation.

Purpose of the Study:

  • To evaluate the association between statin use and outcomes including patency, limb salvage, and survival in patients with CLI undergoing revascularization.
  • To identify factors independently associated with survival in this patient cohort.

Main Methods:

  • Retrospective review of 717 patients who underwent revascularization for intermittent claudication or CLI between May 2001 and December 2009.
  • Patients were stratified into statin and non-statin groups based on therapy at the time of revascularization.
  • Comparison of early postoperative outcomes, graft patency, limb salvage rates, and survival between the groups.

Main Results:

  • Of 717 patients, 397 (55.4%) were on statins. Major adverse cardiac events (MACE) were significantly lower in the statin group.
  • Graft patency and limb salvage rates were comparable between statin and non-statin users.
  • Survival rates were significantly higher in patients receiving statin therapy.

Conclusions:

  • Statin therapy is associated with improved survival in patients undergoing revascularization for chronic limb ischemia.
  • Statin use did not demonstrate a significant association with improved long-term graft patency or limb salvage rates.
  • Non-statin use, coronary artery disease, COPD, renal insufficiency, critical limb ischemia, and age >70 were independent predictors of decreased survival.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
630